Vitamin K antagonist use induces calcification and atherosclerotic plaque progression resulting in increased hypercoagulability

AIMS: Vascular calcification is a hallmark of atherosclerotic burden and can predict the cardiovascular outcome. Vitamin K antagonists (VKA) are widely used anticoagulant drugs to treat patients at risk of arterial and venous thrombosis but are also associated with increase vascular calcification pr...

Descripción completa

Detalles Bibliográficos
Autores principales: van Gorp, Rick H, Baaten, Constance C F M J, Habibi, Anxhela, Jaminon, Armand M G, Peeters, Frederique E C M, Leenders, Peter, Crijns, Harry J G M C, Heemskerk, Johan W M, Reutelingsperger, Chris P, Spronk, Henri M, Schurgers, Leon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241573/
https://www.ncbi.nlm.nih.gov/pubmed/35919270
http://dx.doi.org/10.1093/ehjopen/oeab017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241573/
https://www.ncbi.nlm.nih.gov/pubmed/35919270
http://dx.doi.org/10.1093/ehjopen/oeab017

Ejemplares similares